Sharps Technology, Inc.
Sharps Technology, Inc. (STSSW) Stock Overview
Explore Sharps Technology, Inc.’s financial performance, market position, analyst ratings, and future outlook.
STSSW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Sharps Technology, Inc. (STSSW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.04 and a market capitalization of 22.6K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Mr. Robert M. Hayes
55
105 Maxess Road, Melville, NY
2022